yes...after attending and just getting back to my office...it would be foolish not to hold and accumulate more.
Uplist to NASDAQ...three more items open.
1. 3 Independent directors (IMHO easy...vetting and appointment 30 days).
2. SP $4.00 or above (RS...easy)
3. Shareholder's Equity $5MM with acquisition of property valued over negative equity plus $5MM... which if you do the math..would have to be over $9MM in value (Property appears to have been selected...but not identified to attendees...IMHO 60-90 days with DD after contract execution)
Roll-out of Salon line...impressive packaging and products
Came out with an spray application of oil for topical application anywhere.
DISTINCTION of PRODUCT...
1. National Certifications of Product purity
2. 100% non THC... 99.5% CBD .5% Non-THC substance, therefore NO THC.
3. Nono-CBN...CBN Oil from Mile-High is further processed (pulverized) to create a NANO-CBN product which results in multiple times the absorption (and effectiveness) of the other major CBD products on the market. It was as explained by lab personnel who flew in from WA state, that CANB CBD products is 1/2 the diameter of a skin pore opening...meaning it does not sit on the surface of the skin as other products do, but freely enters through the skin without absorption issues which competitors have.
Compelling testimonials by Vet, but even more impressive was Medical Advisory Board DR who went from constant pain and limping and being told he would have to have a knee replacement to eliminate swelling and pain...to playing golf again...and no impediment to his gate.
DR centered marketing (they do the selling to their patients) growing with DR referrals/inquires every day. But also has direct to the consumer and retail strategies. In final stage of very large retail drug store approval process.
Northwell Hospital System, largest hospital system in NY, has approved CANB's hemp oil products for its on site pharmacies...(huge) and is now being stocked. Only 3 companies were chosen and CANB was one of them (with SAM device offered...which they can only acquire/lease via CANB)
SAM ultrasound device (clinical test by NIH and approved by FDA) is flying off the shelves with DR group orders...revenue from both leasing of units and selling of application pads (think selling razor blades for razor blade handles) reoccurring revenue. Big money center for Drs (and CANB)...without being specific.
ALSO had a discussion with exec on requests from family from Hospice patients to use CANB product instead of morphine so that patient can experience better quality of life (being aware) at end of life...some states it can be administered with patient consent.
What's not to like...except SP right now?
AI
Market Data 
Markets 
